Get the Stockscreener App
54.40
0.07%
-0.04
After Hours:
54.40
Radnet Inc stock is traded at $54.40, with a volume of 422.99K.
It is down -0.07% in the last 24 hours and down -5.93% over the past month.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
See More
Previous Close:
$54.44
Open:
$54.925
24h Volume:
422.99K
Relative Volume:
0.49
Market Cap:
$4.28B
Revenue:
$2.14B
Net Income/Loss:
$22.05M
P/E Ratio:
-301.05
EPS:
-0.1807
Net Cash Flow:
$101.96M
1W Performance:
+3.84%
1M Performance:
-5.93%
6M Performance:
-34.46%
1Y Performance:
-4.17%
1-Day Range:
$53.62
$55.99
1-Week Range:
$51.92
$55.99
52-Week Range:
$50.76
$85.84
Radnet Inc Stock (RDNT) Company Profile
Name
Radnet Inc
Sector
Industry
Phone
(310) 478-7808
Address
1510 COTNER AVE, LOS ANGELES, CA
Compare RDNT vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RDNT
Radnet Inc
|
54.40 | 4.28B | 2.14B | 22.05M | 101.96M | -0.1807 |
TMO
Thermo Fisher Scientific Inc
|
448.28 | 167.00B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
172.00 | 122.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
559.37 | 43.63B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
342.37 | 33.48B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
114.96 | 32.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
Radnet Inc Stock (RDNT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-13-25 | Initiated | B. Riley Securities | Buy |
| Mar-05-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-06-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-31-23 | Initiated | Truist | Buy |
| Mar-31-23 | Initiated | CJS Securities | Market Outperform |
| Mar-03-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Mar-15-19 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-14-18 | Initiated | Raymond James | Strong Buy |
| Aug-22-17 | Upgrade | Jefferies | Hold → Buy |
| Jun-02-16 | Initiated | Sterne Agee CRT | Neutral |
| Apr-15-16 | Initiated | Sidoti | Buy |
| Mar-17-09 | Reiterated | Jefferies & Co | Buy |
| Oct-15-08 | Initiated | RBC Capital Mkts | Sector Perform |
| Jul-14-08 | Upgrade | Stanford Research | Hold → Buy |
| Apr-02-08 | Upgrade | Morgan Keegan | Mkt Perform → Outperform |
| Mar-14-08 | Downgrade | Morgan Keegan | Outperform → Mkt Perform |
| Dec-19-07 | Initiated | Leerink Swann | Outperform |
| Dec-07-07 | Initiated | Stanford Research | Hold |
| Nov-07-07 | Initiated | Morgan Keegan | Outperform |
| Oct-19-07 | Initiated | Deutsche Securities | Buy |
| Jun-18-07 | Reiterated | Jefferies & Co | Buy |
| May-22-07 | Initiated | Jefferies & Co | Buy |
View All
Radnet Inc Stock (RDNT) Latest News
RadNet Q1 earnings call highlights - MSN
RadNet, Inc. (RDNT) Stock Analysis: Unveiling a 65% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Assessing RadNet (RDNT) Valuation After Recent Share Weakness And AI Imaging Growth Hopes - Yahoo Finance
RadNet’s SWOT analysis: imaging stock faces screening headwinds - Investing.com
Neurophet taps US imaging leader Tanenbaum to boost North America AI pushCHOSUNBIZ - Chosunbiz
FDA clears prostate AI solution from RadNet subsidiary DeepHealth - Radiology Business
Neurophet Recruits Neuroimaging Expert Lawrence Tanenbaum as Scientific Advisor - Seoul Economic Daily
RDNT Maintained by Barclays -- Price Target Lowered to $65.00 - GuruFocus
RadNet Is Maintained at Overweight by Barclays - Moomoo
Assessing RadNet (RDNT) Valuation After Revenue Growth And A Narrower Quarterly Net Loss - simplywall.st
Truist Financial Remains a Buy on Radnet (RDNT) - The Globe and Mail
Barclays Maintains RadNet(RDNT.US) With Buy Rating, Cuts Target Price to $65 - Moomoo
Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts - Benzinga
Earnings call transcript: RadNet Q1 2026 sees revenue beat, stock surges - Investing.com Nigeria
Truist Financial Maintains RadNet(RDNT.US) With Buy Rating, Announces Target Price $90 - Moomoo
RadNet stock (US75025X1000): Results and imaging demand in focus - AD HOC NEWS
Does Q1 Revenue Beat and Narrower Losses Reshape the Bull Case For RadNet’s AI Strategy (RDNT)? - simplywall.st
Why RadNet is betting heavily on AI to reshape radiology workflows - Cardiovascular Business
Earnings call transcript: RadNet Q1 2026 sees revenue growth despite EPS miss - Investing.com Nigeria
GoodRx, RadNet, Addus HomeCare, Novavax, and Mettler-Toledo Shares Plummet, What You Need To Know - Yahoo Finance
RadNet Inc stock (US75025X1000): diagnostics specialist in focus after latest quarterly figures - AD HOC NEWS
RadNet signals 2026 ARR of more than $140M while raising imaging center guidance by $30M - MSN
Net margin % of RadNet, Inc. – BMV:RDNT - TradingView
Total liabilities & shareholders' equities of RadNet, Inc. – BMV:RDNT - TradingView
Net margin % of RadNet, Inc. – BIVA:RDNT - TradingView
RadNet, Inc. Balance Sheet – BMV:RDNT - TradingView
RadNet, Inc. Statistics – BMV:RDNT - TradingView
RadNet stock (US75025X1000): imaging specialist rallies after strong Q1 and upbeat 2025 outlook - AD HOC NEWS
RDNT Q1 Deep Dive: Advanced Imaging, Digital Health and Acquisitions Drive Growth - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO) and Radnet (RDNT) - The Globe and Mail
T. Rowe Price (NASDAQ: RDNT) holds 5.4% of RadNet, 4.15M shares - Stock Titan
Jefferies Maintains RadNet(RDNT.US) With Buy Rating, Raises Target Price to $95 - Moomoo
(RDNT) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Analysts Have Made A Financial Statement On RadNet, Inc.'s (NASDAQ:RDNT) First-Quarter Report - Sahm
The RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo! Finance Canada
RadNet Inc (RDNT) Stock Down 5.4% -- Now Undervalued? GF Score: 82/100 - GuruFocus
RadNet Drops 5.9% Amid Sector-Wide Selling - AlphaStreet
RadNet (RDNT) Q1 2026 Earnings Transcript - AOL.com
RadNet Earnings: AI Fuels Revenue Beat And Guidance Raise - Trefis
Earnings To Watch: RadNet (RDNT) Reports Q1 Results Tomorrow - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Radnet (RDNT) and MBX Biosciences, Inc. (MBX) - The Globe and Mail
Barclays Maintains RadNet(RDNT.US) With Buy Rating, Maintains Target Price $70 - Moomoo
Q1 2026 RadNet Inc Earnings Call Transcript - GuruFocus
RadNet stock (US75025X1000): Q1 2026 revenue surges 22% despite net loss - AD HOC NEWS
Did Record Q1 Results and New AI JV Just Shift RadNet's (RDNT) Investment Narrative? - Sahm
RadNet (RDNT) Q1 Loss Widens Again And Tests Bullish AI Margin Narrative - Sahm
RadNet revenue up 22.1% to USD 575.6M in Q1 2026 - Medical Buyer
RadNet, Inc. (NASDAQ:RDNT) Q1 2026 Earnings Call Transcript - Insider Monkey
RadNet Inc (RDNT) Q1 2026 Earnings Call Highlights: Record Reven - GuruFocus
RadNet Q1 Net Loss Narrows, Service Revenue Increases - Moomoo
RadNet Earnings Call Highlights AI-Driven Growth - TipRanks
Radnet Inc Stock (RDNT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):